Combination of type I diabetes mellitus and diabetes associated with GCK gene mutation: features of the clinical course in puberty

Автор: Cherkasova Yulia B., Pavlov Bogdan V., Sokolova Alyona I., Gladyshev Mikhail A., Kurochkin Artem D., Dukova Alexandra A., Sklyarov Bogdan A.

Журнал: Cardiometry @cardiometry

Статья в выпуске: 24, 2022 года.

Бесплатный доступ

This article discusses a clinical case of the manifestation of MODY2 diabetes, which complicated the course of type I diabetes mellitus in a patient of puberty. For 9 months, the dynamics of the patient's condition was monitored, who was on inpatient treatment in the endocrinology department of the State Medical Institution of the Tambov City Hospital for the entire period of observation. The criteria for daily monitoring of the patient's clinical condition were: blood glucose and glycated hemoglobin, the level of glucosuria, the concentration of ketone bodies in the blood and acetone in the urine. The patient underwent insulin therapy and infusion therapy. Despite the ongoing treatment, including, among other things, the treatment of complications of the underlying disease, by the 6th month the patient's condition worsened to an extremely severe degree. Additional laboratory and instrumental diagnostic studies were conducted, including a molecular genetic study for diabetes typing, the results of which made it possible to determine the cause of the progressive course of type I diabetes mellitus, which was the clinical manifestation of MODY2 diabetes with the development of insulin tolerance against the background of hormonal adjustment of puberty. The problem of timely and accurate diagnosis, and, accordingly, correct treatment, of type I diabetes mellitus combined with MODY2 diabetes, remains urgent and serious, due to the difficulty of interpreting differential diagnostic criteria with progressive type I diabetes mellitus of childhood and adolescence, which in turn can lead to multiple complications, including fatal exodus.

Еще

Mody, type i diabetes mellitus, blood glucose level, gen gck

Короткий адрес: https://sciup.org/148326586

IDR: 148326586   |   DOI: 10.18137/cardiometry.2022.24.210216

Список литературы Combination of type I diabetes mellitus and diabetes associated with GCK gene mutation: features of the clinical course in puberty

  • Dedov II, et al. Diabetes mellitus in the Russian Federation: prevalence, morbidity, mortality, parameters of carbohydrate metabolism and the structure of hypoglycemic therapy according to the Federal DM Registry, status 2017. Diabetes mellitus. 2018; 21(3): 144-159. [in Russian]
  • Sultanaliva RB, et al. Epidemiological aspects of diabetes mellitus in Kyrgyzstan. Bulletin of KRSU. 2016; vol. 16 (11): 140-144.
  • Sharofova MU, Sagdieva ShS, Yusufi SD. Diabetes mellitus: current state of the art. Avicenna Bulletin. 2019; 1:502-12. [in Russian]
  • Brunerova L, et al. Use of oral antidiabetic drugs in the treatment of Maturity-Onset Diabetes of the Young (MODY): a minireview. Diabetes Metab Res Rev. 2018; 34(1):2940.
  • Urbanová J, Brunerová L, Brož J (2018) Hidden MODY – looking for a Needle in a Haystack. Front Endocrinol (Lausanne). 2018; 9:355.
  • Ken Munene Nkonge, Dennis Karani Nkonge, Teresa Njeri Nkonge The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity- onset diabetes of the young (MODY) Clin Diabetes Endocrinol. 2020 Nov 4; 6(1):20.
  • Kuraeva TL, et al. Molecular genetic and clinical variants of MODY2 and MODY3 in children in Russia. Problems of endocrinology. 2015; 5:14-25. [in Russian]
  • Cherkasova YuB, et al. The combination of type I diabetes mellitus and diabetes associated with a mutation in the GCK gene. Issues of history. 2022; 8-2:280-7. EDN AENSBB. [in Russian]
  • Zubkova NA, et al. Clinical and molecular genetic characteristics of MODY1-3 cases in the Russian Federation identified by NGS results. Problems of endocrinology. 2017; 63(6): 369-78. [in Russian]
  • Ovsyannikova AK, et al. MODY in Siberia - molecular genetics and clinical manifestations. Diabetes. 2017; 20(1): 5-12. [in Russian]
  • Kononenko IV, et al. Difficulties in diagnosing diabetes mellitus type MODY2 in adults. Diabetes. 2019; 22(4): 384-91. [in Russian]
  • Kitao N, et al. The role of glucokinase and insulin receptor substrate-2 in the proliferation of pancreatic beta cells induced by short-term high-fat diet feeding in mice. Metabolism. 2018; 85: 48-58. [in Russian]
  • Jun Shirakawa, Yasuo Terauchi. Newer perspective on the coupling between glucose-mediated signaling and β-cell functionality. Endocr J. 2020; Jan 28; 67(1):1-8.
  • Vella A, et al. Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator. Science translational medicine. 2019; 11(475): eaau3441. [in Russian]
  • Carlsson A, et al. Absence of islet autoantibodies and modestly raised glucose values at diabetes diagnosis should lead to testing for MODY: lessons from a 5-year pediatric Swedish National Cohort Study. Diabetes Care.2020; 43(1): 82–89. [in Russian]
  • Steele AM, et al. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA. 2014; 311(3): 279-286. [in Russian]
  • Voevoda MI, et al. Molekuljarnaja genetika MODY. Terapevticheskij arhiv. 2016; 88(4): 117-124. [in Russian]
Еще
Статья научная